More Americans are turning to peptides for muscle building, skin rejuvenation, and to try and live longer even though the ...

A new study reveals women are three times more likely to experience severe long COVID due to biological differences.

R&D Day showcased remarkable Investigator optimism, continued strengthening supportive data, and significant progress with Phase 3 OVATION 3 Study in pursuit of first frontline immunotherapy for advan ...

Prior exposure to coronaviruses that cause ordinary colds can boost the immune system's ability to attack a vulnerable site ...

We're officially in respiratory virus season, and it's expected to last through mid-May. There are ways to protect against ...

The respiratory virus season is expected to last through mid-May, but there are natural ways to protect against viruses like ...

Entered into an exclusive license agreement with Dynavax for the Company’s COVID-19 oral pill vaccine candidate for potential cumulative proceeds of up to $700 million plus royalties Completed ...

Three new top-rated children’s hospitals adopt QUELIMMUNE therapy for ultra-rare pediatric Acute Kidney Injury ...

We investigate whether cold and flu nose sprays such as Vicks First Defence can help fight off common winter bugs ...